Innovative Gastrointestinal Drug Delivery Systems: Nanoparticles, Hydrogels, and Microgrippers
Frontiers in Bioscience-Landmark · 21.02.2025 · 30 (2)
DOI: 10.31083/fbl25281 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 21.02.2025. Verfasst von Haiming Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA. Hauptthemen laut MEDLINE: Hydrogels, Drug Delivery Systems, Nanoparticles, Gastrointestinal Tract. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Crohn's and Colitis Foundation, Leona M. and Harry B. Helmsley Charitable Trust, NIH HHS.
Abstract (Originalsprache)
Over the past decade, new technologies have emerged to increase intrinsic potency, enhance bioavailability, and improve targeted delivery of drugs. Most pharmaceutical formulations require multiple dosing due to their fast release and short elimination kinetics, increasing the risk of adverse events and patient non-compliance. Due to these limitations, enormous efforts have focused on developing drug delivery systems (DDSs) for sustained release and targeted delivery. Sustained release strategies began with pioneering research using silicone rubber embedding for small molecules and non-inflammatory polymer encapsulation for proteins or DNA. Subsequently, numerous DDSs have been developed as controlled-release formulations to deliver systemic or local therapeutics, such as small molecules, biologics, or live cells. In this review, we discuss the latest developments of DDSs, specifically nanoparticles, hydrogels, and microgrippers for the delivery of systemic or localized drugs to the gastrointestinal (GI) tract. We examine innovative DDS design and delivery strategies tailored to the GI tract’s unique characteristics, such as its extensive length and anatomical complexity, varying pH levels and enzymatic activity across different sections, and intrinsic peristalsis. We particularly emphasize those designed for the treatment of inflammatory bowel disease (IBD) with in vivo preclinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
- Department of Oncology, Sidney Kimmel Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
- The Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, MD 21231, USA.
Förderung
- Crohn's and Colitis Foundation
- Leona M. and Harry B. Helmsley Charitable Trust
- NIH HHS
- Crohn’s and Colitis Foundation
- National Institutes of Health
Zitieren
APA
Chen, H., Islam, W., El Halabi, J., Li, L., & Selaru, F. M. (2025). Innovative Gastrointestinal Drug Delivery Systems: Nanoparticles, Hydrogels, and Microgrippers. Frontiers in Bioscience-Landmark, 30(2). https://doi.org/10.31083/fbl25281
Vancouver
Chen H, Islam W, El Halabi J, Li L, Selaru FM. Innovative Gastrointestinal Drug Delivery Systems: Nanoparticles, Hydrogels, and Microgrippers. Frontiers in Bioscience-Landmark. 2025;30(2). doi:10.31083/fbl25281
BibTeX
@article{Chen2025,
author = {Chen, Haiming and Islam, Waliul and El Halabi, Jessica and Li, Ling and Selaru, Florin M},
title = {Innovative Gastrointestinal Drug Delivery Systems: Nanoparticles, Hydrogels, and Microgrippers},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
volume = {30},
number = {2},
doi = {10.31083/fbl25281}
}
EUVIMED